Solesence Inc
Research Solesence Inc (SLSN) on Bullrun: valuation model: 56.8% overvalued, market cap USD 56.30M, P/E 64.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSLSN
- ExchangeNASDAQ
- CountryUnited States
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyUSD
- Valuation signal56.8% overvalued
- Market capUSD 56.30M
- P/E64.8
- Financial periodFY2025
- RevenueUSD 62.06M
- Revenue growth18.6%
- Net incomeUSD 1.79M
- Gross margin25.9%
Valuation Snapshot
Bullrun's latest valuation model marks Solesence Inc as 56.8% overvalued; latest market cap is USD 56.30M; P/E is 64.8.
About Solesence Inc
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products.
Frequently asked questions
Is Solesence Inc overvalued or undervalued?
Bullrun's valuation model currently marks Solesence Inc as 56.8% overvalued.
What is Solesence Inc's market cap?
Solesence Inc's market capitalization is USD 56.30M.
What is Solesence Inc's P/E ratio?
Solesence Inc's price-to-earnings (P/E) ratio is 64.8.
What does Solesence Inc do?
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients.